IP Verse

Use Of Cannabinoids In The Treatment Of Epilepsy - EP3206716

The patent EP3206716 was granted to GW Pharma on Jul 29, 2020. The application was originally filed on Oct 14, 2015 under application number EP15784111A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3206716

GW PHARMA
Application Number
EP15784111A
Filing Date
Oct 14, 2015
Status
Granted And Under Opposition
Jun 26, 2020
Grant Date
Jul 29, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEApr 29, 2021CABINET BECKER ET ASSOCIESWITHDRAWN

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2008094181
INTERNATIONAL-SEARCH-REPORTWO2012093255
INTERNATIONAL-SEARCH-REPORTWO2015193668
OPPOSITIONEP3157512
OPPOSITIONWO2008094181
OPPOSITIONWO2012093255
OPPOSITIONWO2015193668

Non-Patent Literature (NPL) Citations (38) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- Alexandra Geffrey ET AL, "American Epilepsy Society | Working Toward a World without Epi", (20140101), URL: https ://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868979#, (20160119), XP055242613 [X] 1-8,10-14 * the whole document * [Y] 1-21-
INTERNATIONAL-SEARCH-REPORT- Anonymous, "GWPharma - GW Pharmaceuticals Announces Epidiolex Receives Fast Track Designation from FDA for the Treatment of Dravet Syndrome", (20140606), URL: http://www.gwpharm.com/GW%20Pharmaceuticals%20Announces%20Epidiolex%20Receives%20Fast%20Track%20Designation%20from%20FDA%20for%20the%20Treatment%20of%20Dravet%20Syndrome.aspx, (20150729), XP055205380 [X] 1-8,13,14 * the whole document * [Y] 1-21-
INTERNATIONAL-SEARCH-REPORT- Anonymous, "Legalization's opening of medical pot research is dream and nightmare - The Denver Post", (20131215), URL: http://www.denverpost.com/ci_24726291/legalizations-opening-medical-pot-research-is-dream-and, (20160115), XP055241747 [X] 1-3,14 * page 3, paragraph 2 *-
INTERNATIONAL-SEARCH-REPORT- Anonymous, "Salutaris Drops Buy Salutaris Drops - Salutaris Drops", (20141012), URL: http://web.archive.org/web/20141012130255/http://salutarisdrops.com/buy-salutaris-drops/, (20160118), XP055242184 [Y] 1-21 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- Anonymous, "Salutaris Drops Cannabidiol for Aicardi Syndrome - Salutaris Drops", (20141012), URL: http://web.archive.org/web/20141012220050/http://salutarisdrops.com/cannabidiol-aicardi-syndrome/, (20160115), XP055241818 [X] 1-8,14 * the whole document * [Y] 1-21-
INTERNATIONAL-SEARCH-REPORT- Catherine Jacobson ET AL, "Survey of Current Cannabidiol Use in Pediatric Treatment-Resistant Epilepsy", (20130422), URL: https://www.thcint.com/uploads/1/9/3/7/19371199/cannabidiol_use_in_pediatric_epilepsy.pdf, (20160105), XP055238831 [X] 1-7,13,14 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- Fred Gardner, "Comes Now Epidiolex(TM) (FDA approves IND studies of CBD)", (20131022), URL: http://www.gwpharm.com/uploads/oshaughnessysarticle-comesnowepidiolex.pdf, (20160119), XP055242879 [Y] 1-21 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- PELLICCIA ET AL., "Treatment with CBD in oily solution of drug- resistant paediatric epilepsies", (20100902), URL: http://www.gwpharm.com/uploads/pelliccia-2002-treatmentwithcbdinoilysolutionofdrug-resistantpediatricepilepsies.pdf, (20160120), XP002753205 [X] 1-4,13,14 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- PORTER ET AL., "Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy", EPILEPSY & BEHAVIOR, (2013), vol. 29, no. 3, pages 574 - 577, XP028775189 [X] 1-7,13,14 * abstract *
INTERNATIONAL-SEARCH-REPORT- MAA ET AL., "The case for medical marijuana in epilepsy", EPILEPSIA, (20140601), vol. 55, no. 6, pages 783 - 786, XP055205357 [X] 1-8,13,14 * abstract *
OPPOSITION- ALEXANDRA GEFFREY et al., "(Abst. 2.427) Cannabidiol: (CBD) for refractory epilepsy in tuberous sclerosis complex (TSC)", American Epilepsy Society, (20140101), pages 1 - 2, XP055956040-
OPPOSITION- Anonymous, "A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults", Clinicaltrials.gov NCT02224690, (20140822), pages 1 - 4, XP055956114-
OPPOSITION- Anonymous, "GWPharma - GW Pharmaceuticals Announces Epidiolex Receives Fast Track Designation from FDA for the Treatment of Dravet Syndrome", GWPharma, (20140606), pages 1 - 5, XP055205380-
OPPOSITION- Anonymous, "GWPharma - GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Childrenand Young Adults With Treatment-Resistant Epilepsy", Press Release, (20141014), pages 1 - 8, XP055956102-
OPPOSITION- Anonymous, "GWPharma - GW Pharmaceuticals Initiates Second Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome", Press Release, (20150611), pages 1 - 5, XP055205375-
OPPOSITION- Anonymous, "GWPharma - GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome", Press release, (20140228), pages 1 - 4, XP055956095-
OPPOSITION- Anonymous, "ILAE Proposal for Revised Terminology for Organiza:on of Seizures and Epilepsies", Epilepsia Lancet, (20100000), pages 1 - 2, XP055206114-
OPPOSITION- Anonymous, "Legalizations opening of medical pot research is dream and nightmare", The Denver Post, (20131215), pages 1 - 6, XP055241747-
OPPOSITION- Anonymous, "Salutaris Drops Buy Salutaris Drops - Salutaris Drops", Salutaris Drops, (20141012), pages 1 - 2, XP055242184-
OPPOSITION- Anonymous, "Salutaris Drops Cannabidiol for Aicardi Syndrome - Salutaris Drops", Salutaris Drops, (20141012), pages 1 - 3, XP055241818-
OPPOSITION- Campos-Castello J., "Lennox-Gastaut syndrome (LGS)", Orphanet, (20030300), pages 1 - 5, URL: https://www.orpha.net/data/patho/GB/uk-Lennox.pdf, XP055956184-
OPPOSITION- CATHERINE JACOBSON et al., "Survey of Current Cannabidiol Use in Pediatric Treatment- Resistant Epilepsy", Department of Neurology , Stanford University, (20130422), page 1, XP055238831-
OPPOSITION- DEVINSKY et al., "Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy", epilepsy Ontario, (20150400), page 1, URL: https://epilepsyontario.org/wp-content/uploads/2015/12/Epidiolex-Cannabidiol-in-Treatment- Resistant-Epilepsy, XP055956080-
OPPOSITION- FRED GARDNER, "Comes Now Epidiolex™ (FDA approves IND studies of CBD)", O'Shaughnessy's online, (20131022), pages 1 - 5, XP055242879-
OPPOSITION- GEDDE M., "Retrospective Case Review of High CBD, Low THC Cannabis Extract (Realm Oil) for Intractable Seizure Disorders", Gedde Whole Health, (20130000), pages 1 - 4, XP055956119-
OPPOSITION- PELLICCIA et al., "Treatment with CBD in oily solution of drug-resistant paediatric epilepsies", 2005 Congress on Cannabis and the Cannabinoids: International Association for Cannabis as Medicine, Leiden, The Netherlands, (20100902), pages 1 - 2, XP055714573-
OPPOSITION- PERTWEE et al., "The Pharmacology and Therapeutic Potential of Cannabidiol", PERTWEE et al., Vincenzo, Cannabinoids, Plenum publishers, (20040000), pages 32 - 83, XP055956222-
OPPOSITION- Seroka R. , Et Al., "AAN 67 th ANNUAL MEETING ABSTRACT Epidiolex (Cannabidiol) in Treatment Resistant Epilepsy", American Academy of Neurology Annual Meeting Abstract, (20150413), page 1, URL: https://www.aan.eom/PressRoom/Home/GetDiqitalAsset/11570, XP055956086-
OPPOSITION- WILLIAMS S., "The Key to Healing Broken Bones May Be Found in This Illegal Drug", The Motley Fool, (20150725), pages 1 - 5, URL: hftps://www.fool.com/investinq/hiqh-qrowth/2015/07/25/the-kev-to-healinq-broken-bones-mav-be-found-in-th.aspx#:~:text=As%20published%20in%20the%20Journal.rats%20in%20just%20eight%20w eeks, XP055956170-
OPPOSITION- ROSENBERG et al., "Cannabinoids and Epilepsy", Neurotherapeutics, (20150818), vol. 12, doi:10.1007/s13311-015-0375-5, pages 747 - 768, XP036033960
OPPOSITION- VANSTRATEN et al., "Update on the Management of Lennox-Gastaut Syndrome", Pediatric Neurology, (20120509), vol. 47, pages 153 - 161, XP055956243
OPPOSITION- PORTER et al., "Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy", Epilepsy & Behaviour, (20130000), vol. 29, no. 3, doi:10.1016/j.yebeh.2013.08.037, pages 574 - 577, XP028775189
OPPOSITION- MAA et al., "The case for medical marijuana in epilepsy", Epilepsia, (20140601), vol. 55, no. 6, doi:10.1111/epi.12610, pages 783 - 786, XP055205357
OPPOSITION- DEVINSKY et al., "Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders", Epilepsia, (20140600), vol. 55, no. 6, doi:10.1111/epi.12631, pages 791 - 802, XP055205354
OPPOSITION- Peter R. Camfield, "Definition and natural history of Lennox-Gastaut Syndrome", Epilepsia, (20110000), vol. 52, pages 3 - 9, XP071211650
OPPOSITION- Montouris Georgia D., "Rational approach to treatment options for Lennox-Gastaut syndrome", Epilepsia, (20110000), vol. 52, pages 10 - 20, XP071211651
OPPOSITION- GRESHAM et al., "Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide", Neuropsychiatric Disease and Treatment, (20100921), vol. 6, pages 639 - 645, XP055956240
OPPOSITION- BABAYEVA et al., "Marijuana Compounds: A Non-Conventional Therapeutic Approach to Epilepsy in Children", J. Addict. Neuropharmacol., (20140930), vol. 1, pages 1 - 9, XP055956201

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents